3-(4-chlorophenyl)-8-methoxy-2H-chromen-2-one | 694455-89-5

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 异黄酮类化合物
• 英文名称: 3-(4-chlorophenyl)-8-methoxy-2H-chromen-2-one
• 英文别名: 3-(4'-chlorophenyl)-8-methoxycoumarin；3-(4-Chlorophenyl)-8-methoxychromen-2-one
• CAS: 694455-89-5
• 化学式: C₁₆H₁₁ClO₃
• 分子量: 286.715
• InChiKey: PQRJPZOOAPBUDG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.12
• 重原子数：
  20.0
• 可旋转键数：
  2.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.06
• 拓扑面积：
  39.44
• 氢给体数：
  0.0
• 氢受体数：
  3.0

反应信息

• 作为反应物：
  描述：

  3-(4-chlorophenyl)-8-methoxy-2H-chromen-2-one 在 1,10-菲罗啉 、 copper(l) chloride 、 sodium hydroxide 作用下， 以 二甲基亚砜 为溶剂， 反应 24.0h， 以42%的产率得到2-(4-氯苯基)-7-甲氧基苯并[b]呋喃
  参考文献：
  名称：

  Copper-catalyzed decarboxylative intramolecular C–O coupling: synthesis of 2-arylbenzofuran from 3-arylcoumarin

  摘要：

  建立了一种铜催化的脱羧分子内 CâO 偶联反应。在氯化铜/1,10-菲罗啉存在的有氧条件下，以 3-芳基香豆素为原料一锅制备了多种 2-芳基苯并呋喃，收率从 26% 到 84%不等。

  DOI：

  10.1039/c3ra46414h
• 作为产物：
  描述：

  对氯苯乙酸 、 邻香草醛 在 乙酸酐 、 三乙胺 作用下， 反应 8.0h， 以60%的产率得到3-(4-chlorophenyl)-8-methoxy-2H-chromen-2-one
  参考文献：
  名称：

  3-Arylcoumarins: Synthesis and potent anti-inflammatory activity

  摘要：

  Chronic inflammation is the persistent and excessive immune response and can lead to a variety of diseases. Aiming to discover new compounds with anti-inflammatory activity, we report herein the synthesis and biological evaluation of 3-arylcoumarins. Thirty five 3-arylcoumarins were prepared through Perkin condensation and further acid-promoted hydrolysis if necessary. In lipopolysaccharide-activated mouse macrophage RAW264.7 cells, 6,8-dichloro-3-(2-methoxyphenyl) coumarin (16) and 6-bromo-8-methoxy-3-(3-methoxyphenyl) coumarin (25) exhibited nitric oxide production inhibitory activity with the IC50 values of 8.5 mu M and 6.9 mu M, respectively, providing a pharmacological potential as anti-inflammatory agents. (C) 2014 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2014.10.033

文献信息

• Copper-catalyzed decarboxylative intramolecular C–O coupling: synthesis of 2-arylbenzofuran from 3-arylcoumarin
  作者：Wen-Chen Pu、Guan-Min Mu、Guo-Lin Zhang、Chun Wang

  DOI：10.1039/c3ra46414h

  日期：——

  A copper-catalyzed decarboxylative intramolecular C–O coupling reaction was established. Under aerobic conditions in the presence of cupric chloride/1,10-phenathroline, a variety of 2-arylbenzofurans were prepared from 3-arylcoumarins in one-pot with yields from 26% to 84%.

  建立了一种铜催化的脱羧分子内 CâO 偶联反应。在氯化铜/1,10-菲罗啉存在的有氧条件下，以 3-芳基香豆素为原料一锅制备了多种 2-芳基苯并呋喃，收率从 26% 到 84%不等。
• Methods of Inhibiting Bacterial Virulence and Compounds Relating Thereto
  申请人：Sperandio Vanessa

  公开号：US20100048573A1

  公开（公告）日：2010-02-25

  The present invention relates to compounds and methods for the treatment of bacterial infections. Because their mechanism of action does not involve killing of bacteria or inhibiting their growth, the potential for these compounds to induce drug resistance in bacteria is minimized. Through inhibiting bacterial virulence, the present invention provides a novel means of treating bacterial infections.

  本发明涉及化合物和方法，用于治疗细菌感染。由于它们的作用机制不涉及杀死细菌或抑制它们的生长，这些化合物诱导细菌耐药性的潜力被最小化。通过抑制细菌的毒力，本发明提供了治疗细菌感染的新方法。
• 3-Arylcoumarins: Synthesis and potent anti-inflammatory activity
  作者：Wenchen Pu、Yuan Lin、Jianshuo Zhang、Fei Wang、Chun Wang、Guolin Zhang

  DOI：10.1016/j.bmcl.2014.10.033

  日期：2014.12

  Chronic inflammation is the persistent and excessive immune response and can lead to a variety of diseases. Aiming to discover new compounds with anti-inflammatory activity, we report herein the synthesis and biological evaluation of 3-arylcoumarins. Thirty five 3-arylcoumarins were prepared through Perkin condensation and further acid-promoted hydrolysis if necessary. In lipopolysaccharide-activated mouse macrophage RAW264.7 cells, 6,8-dichloro-3-(2-methoxyphenyl) coumarin (16) and 6-bromo-8-methoxy-3-(3-methoxyphenyl) coumarin (25) exhibited nitric oxide production inhibitory activity with the IC50 values of 8.5 mu M and 6.9 mu M, respectively, providing a pharmacological potential as anti-inflammatory agents. (C) 2014 Elsevier Ltd. All rights reserved.
• US8252841B2
  申请人：——

  公开号：US8252841B2

  公开（公告）日：2012-08-28
• [EN] CANCER METASTASIS INHIBITOR<br/>[FR] INHIBITEUR DE MÉTASTASES CANCÉREUSES<br/>[JA] 癌転移抑制剤
  申请人：KYOTO PHARMACEUTICAL UNIV

  公开号：WO2020130120A1

  公开（公告）日：2020-06-25

  本発明は、新規な癌転移抑制剤に関する。本発明によれば、式（Ｉ）： [式中の各記号の定義は、明細書に記載の通りである。] で表される化合物、又はその医薬上許容される塩を有効成分として含有することを特徴とする癌転移抑制剤を提供することができる。